Fresenius to redeem €450 million 4% notes due 2024 on Dec. 4

By Mary-Katherine Stinson

Lexington, Ky., Dec. 1 – Fresenius SE & Co. KGaA announced it will redeem its €450 million 4% notes due 2024 (ISIN: XS1026109543, XS1026109204) on Dec. 4, according to a notice.

The Rule 144A and Regulation S notes will be redeemed in full at par plus a make-whole amount, calculated at Bunds plus 50 basis points, plus accrued interest.

Accrued interest will total €13.66667 per note, bringing the redemption price to €1,013.66667 per note plus the make-whole amount, if any.

The issuer intends to publish a notice with the redemption price five business days prior to the redemption date.

Fresenius is a German health care group. The company provides products and services for dialysis, hospitals, and outpatient medical care.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.